Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
49.23
+0.26 (0.53%)
At close: Aug 13, 2025, 4:00 PM
48.96
-0.27 (-0.55%)
Pre-market: Aug 14, 2025, 9:01 AM EDT
Qiagen Revenue
Qiagen had revenue of $533.54M in the quarter ending June 30, 2025, with 7.49% growth. This brings the company's revenue in the last twelve months to $2.04B, up 5.15% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.04B
Revenue Growth
+5.15%
P/S Ratio
5.25
Revenue / Employee
$341,892
Employees
5,967
Market Cap
10.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
QGEN News
- 7 days ago - Qiagen N.V. (QGEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability - Business Wire
- 22 days ago - QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire
- 5 weeks ago - QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire
- 6 weeks ago - QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board - Business Wire
- 2 months ago - Qiagen and Gencurix Enter Clinical Diagnostics Partnership - Market Watch
- 2 months ago - QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - Business Wire
- 2 months ago - QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) - Business Wire